Small GTPases in lymphocyte biology. Rho proteins take center stage

Immunologic Research

Volumn 20, Issue 1, 1999, Pages 29-42

  Henning, Stefan ^a   Cleverley, Steve ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cdc42; GTPases; Lymphocytes; Rac; Rho; Signaling

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LYMPHOCYTE ANTIGEN RECEPTOR; RAS PROTEIN; RHO FACTOR;

HUMAN; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0032813846     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786505     Document Type: Review

References (59)

1. 1 Van Aelst L, D'Souza-Schorey C: Rho GTPases signaling networks. Genes & Dev 1997;11: 2295-2322.
2. 2 Collins TL, Deckert M, Altman A: Views on Vav. Immunol Today 1997;18:221-225.
3. 3 Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependend activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997; 385:169-172.
4. 4 Han J, Luby-Phelps K, Das K, Shu X, Xia Y, Mosteller RD, et al.: Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998; 279:558-560.
5. 5 Tuosto L, Michel F, Acuto O: p95vav associates with tyrosinephosphorylated SLP-76 in antigen-stimulated T cells. J Exp Med 1996;184:1161-1166.
6. 6 Wu J, Zhao Q, Kurosaki T, Weiss A: The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction. J Exp Med 1997;185: 1877-1882.
7. 7 Weng WK, Jarvis L, LeBien TW: Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 1994;269.32,514-32,521.
8. + thymocytes. Nature 1995;374: 474-476.
9. 9 Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, et al.: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995;374:467-470.
10. 10 Turner M, Mee PJ, Walters AE, Quinn ME, Mellor AL, Zamoyska R, et al.: A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 1997; 7:451-460.
11. 11 Wange RL, Samelson LE: Complex complexes, signaling at the TCR. Immunity 1996;5:197-205.
12. 12 Michiels F, Habets GGM, Stam JC, van der Kammen RA, Collard JG: A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995;375:338-340.
13. 13 Ward SG, June CH, Olive D: PI 3-kinase, a pivotal pathway in T cell activation. Immunol Today 1996; 17:187-198.
14. 14 Reif K, Nobes CD, Thomas G, Hall A, Cantrell DA: Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/ Rho-dependent effector pathways. Curr Biol 1996;6:1445-1455.
15. 15 Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF, et al.: Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO 1995;14:276-285.
16. 16 Genot E, Cleverley S, Henning S, Cantrell DA: Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J 1996;15:3923-3933.
17. 17 Rapoport MJ, Lazarus AH, Jaramillo A, Speck B, Delovitch TL: Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med 1993; 177:1221-1226.
18. 18 Rao A, Luo C, Hogan PG: Transcription factors of the NFAT family, regulation and function. Ann Rev Immunol 1997;15:707-747.
19. 19 Izquierdo M, Leevers SJ, Marshall C, Cantrell DA: p21ras couples the T cell antigen receptor to Extracellular Signal-regulated Kinase 2 in T lymphocytes. J Exp Med 1993;78:1199-1208.
20. 20 Rudd CE: Upstream-downstream, CD28 cosignaling pathways and T cell function. Immunity 1996;4: 527-534.
21. 21 Nunes JA, Collette Y, Truneh A, Olive D, Cantrell DA: The role of p21ras in CD28 signal transduction. Triggering of CD28 with antibodies, but not the ligand B7-1 activates p21ras. J Exp Med 1994; 180:1067-1076.
22. 22 Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, et al.: p62(dok), a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997;88: 197-204.
23. 23 Nunes JA, Truneh A, Olive D, Cantrell DA: Signal transduction by CD28 ligands B7-1 and B7-2, CD28 regulation of tyrosine kinase adapter molecules. J Biol Chem 1996;251:1591-1598.
24. 24 Yamanashi Y, Baltimore D: Identification of the Abl-and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997; 88:205-211.
25. 25 Turner H, Cantrell DA: Distinct Ras effector pathways are involved in FceRI regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J Exp Med 1997;185:43-57.
26. 26 Yablonski D, Kane LP, Qian D, Weiss A: A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J 1998; 17:5647-5657.
27. 27 Turner H, Gomez M, McKenzie E, Kirchem A, Lennard A, Cantrell DA: Rac-1 regulates nuclear factor of activated T cells (NFAT)C1 nuclear translocation in response to Fce receptor type 1 stimulation of mast cells. J Exp Med 1998;188:527-537.
28. 28 Lamarche N, Tapon N, Stowers L, Burbelo PD, Aspenstrom P, Bridges T, et al.: Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 1997;87:519-529.
29. 29 Westwick JK, Lambert QT, Clark GJ, Symons M, Van Aelst L, Pestell RG, et al.: Rac regulation of transformation, gene expression, and actin organization by multiple PAK-independent pathways. Mol Cell Biol 1997;17:1324-1335.
30. 30 von Boehmer H: Aspects of lymphocyte developmental biology. Immunol. Today 1997;18:260-262.
31. 31 Fehling HJ, von Boehmer H: Early αβ T cell development in the thymus of normal and genetically altered mice. Curr Opinion Immunol 1997;9:263-275.
32. 32 DiSanto JP, Rodewald H-R: In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr Opinion Immunol 1998;10:196-207.
33. 33 Henning SW, Gallandrini R, Hall A, Cantrell DA: The GTPase Rho has a critical regulatory role in thymus development. EMBO J 1997; 16:2397-2407.
34. 34 Galandrini R, Henning SW, Cantrell DA: Different functions of the GTPase Rho in pro-thymocytes and late pre-T cells. Immunity 1997;7:163-174.
35. 35 Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ: Defects in B lymphocyte maturation and T lmphocyte activation in mice lacking JAK3. Science 1995;270: 794-797.
36. 36 von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a non-redundant cytokine. J Exp Med 1995;181:1519-1526.
37. 37 Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, et al.: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180:1955-1960.
38. 38 Cao X, Shores EW, Hu-Li J, Anver M, Kelsall BL, Russell SM, et al.: Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 1995;2:223-238.
39. 39 Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon J, Strasser A: Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor deficient mice but not in mutant rag-1-/-mice. Cell 1997;89:1011-1019.
40. 40 Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman I: Bcl-2 rescues T Lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997;89:1033-1041.
41. 41 von Freeden-Jeffry U, Solvason N, Howard M, Murray R: The earliest T lineage-commited cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997;7:147-154.
42. 42 Mombaerts P, Anderson SJ, Perlmutter RM, Mak TW, Tonegawa S: An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity 1994;1.
43. 43 Fehling H-J, Iritani BM, Krotkova A, Forbush KA, Laplace C, Perlmutter RM, et al.: Restoration of thymopoiesis in pTa-/-mice by anti-CD3e antibody treatment or with transgenes encoding activated lck or tailless pTa. Immunity 1997;6:703-714.
44. 44 Levin SD, Abraham KM, Anderson SJ, Forbush KA, Perlmutter RM: The protein tyrosine kinase p56lck regulates thymocyte development independently of its interaction with CD4 and CD8 coreceptors. J Exp Med 1993;178: 245-255.
45. 45 Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E, et al.: Profound block in thymocyte development in mice lacking p56lck. Nature 1992;357: 161-164.
46. 46 Henning SW, Cantrell DA: p56lck signals for regulating thymocyte development can be distinguished by their dependency on Rho function. J Exp Med 1998;188:931-939.
47. 47 Ridley AJ, Hall A: The small GTP binding protein rho regulates the assemlby of focal adhesions an actin stress fibers in response to growth factors. Cell 1992;70:389-399.
48. 48 Nobes C, Hall A: Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibres, lamellipodia and filopodia. Cell 1995;81:53-62.
49. 49 Stowers L, Yelon D, Berg LJ, Chant J: Regulation of the polarization of T cells towards antigen-presenting cells by Ras-related GTPase Cdc42. Proc Nat Acad Sci 1995;92:5027-5031.
50. 50 Kirchhausen T, Rosen FS: Disease mechanism, unravelling Wiskott-Aldrich syndrome. Curr Biol 1996; 6:676-678.
51. 51 Tapon N, Hall A: Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opinion Cell Biol 1997;9: 86-92.
52. 52 Di Cunto F, Calautti E, Hsiao J, Ong L, Topley G, Turco E, et al.: Citron Rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing the Rho-Rac-binding protein citron. J Biol Chem 1998;273:29,706-29,711.
53. 53 Denhardt DT: Signal-transducing protein phosphorylution cascades mediated by Ras/Rho proteins in the mammalian cell, the potential for multiplex signalling. Biochem J 1996;318:729-747.
54. 54 Narumiya S, Ishizaki T, Watanabe N: Rho effectors and reorganisation of the actin cytoskeleton. FEBS L 1997;410:68-72.
55. 55 Lu X, Wu X, Plemenitas A, Yu H, Sawai ET, Abo A, Peterlin BM: Cdc42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr Biol 1996;6:1677-1684.
56. 56 Teramoto H, Salem P, Robins KC, Bustelo XR, Gutkind JS: Tyrosine phosphorylation of the vav proto-oncogene product links FceRI to the Rac-JNK pathway. J Biol Chem 1997;272:10,751-10,755.
57. 57 Fanger GR, Lassignal Johnson N, Johnson GL: MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J 1997;16:4961-4972.
58. 58 Chong LD, Traynor-Kaplan A, Bokoch GM, Schwartz MA: The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell 1994;79:507-513.
59. 59 Sahai E, Alberts AS, Treisman R: Rho A effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 1998;17:1350-1361.